THRIVE-2 met all primary and secondary endpoints at the 15-week primary analysis timepoint after 5 infusions of veligrotug.
With Covid rates still relatively high in the UK, it's important to know what could be causing a sore throat in the winter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback